Middle East and Africa Medical Enzyme Technology Market Size, Share, and Analysis by 2028
Historic Data: 2019-2020 | Base Year: 2021 | Forecast Period: 2022-2028Middle East and Africa Medical Enzyme Technology Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Enzyme Type (Digestive Enzymes, Thrombolytic Enzymes, Hydrolases, and Endonucleases); Application (Disease Treatment, Diagnostic Tools, Biomedical Research, and Others)
- Report Date : Sep 2021
- Report Code : TIPRE00025044
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 159
The medical enzyme technology market in Middle East and Africa is expected to grow from US$ 176.7 million in 2021 to US$ 245.2 million by 2028; it is estimated to grow at a CAGR of 4.8% from 2021 to 2028.
Biopharmaceuticals are among the growing business segments of the pharmaceutical and biotechnology industries. Since their introduction in 1982, biopharmaceutical drugs have revolutionized the treatment of a broad spectrum of diseases, and they are increasingly used in nearly all medicine branches. Despite the immense time and financial effort required, the Middle East and Africa Medical Enzyme Technology market of biopharmaceuticals is rapidly growing.
Countries such as UAE, and Saudi Arabia have also registered a significant number of positive patients. These regions are developing in terms of the medical industry. The countries in these regions are highly dependent on medical devices and biopharmaceuticals products. Therefore, countries have faced several challenges for their requirements. Following COVID-19 and government actions, certain enzyme applications, such as pharmaceuticals and detergents, are likely to see an increase in demand. The increase in medical research and diagnostics has been a major factor in the increase in enzyme demand, as enzymes are widely used in medicine and pharmaceutical engineering. Some companies in the area are working with other businesses to consolidate all facilities under one roof for the convenience of the clients. DuBiotech, for example, is actively forming affiliations and partnerships with prestigious universities, specialist hospitals, global regulatory bodies, and other research parks to link the DuBiotech group with the global Life Sciences industry. DuBiotech includes a group of Biotechnology, Pharmaceutical, and Research firms, including global leaders such as Pfizer, Amgen, Merck Serono, and Genzyme, in keeping with its philosophy of being the major life science centre in the Middle East. Many small and medium-sized enterprises are also involved in the city. Such initiatives will help the gain traction for the medical enzymes technology market in near future.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the medical enzyme technology market. The Middle East and Africa medical enzyme technology market is expected to grow at a good CAGR during the forecast period.
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Middle East and Africa Medical Enzyme Technology Market Segmentation
By Enzyme Type
- Digestive Enzymes
- L-asparaginase
- Lactase
- Others
- Thrombolytic Enzymes
- Streptokinase
- Urokinase
- Others
- Hydrolases Enzymes
- Hyaluronidase
- Lysozymes
- Others
- Endonucleases Enzymes
- Benzonase
- Others
By Application
- Disease Treatment
- Diagnostic Tools
- Biomedical Research
- Others
By Country
Middle East and Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East and Africa
Companies Mentioned
- Merck Kgaa
- Thermo Fisher Scientific Inc.
- Novozymes
- Takeda Pharmaceutical Company Limited
- Agilent Technologies, Inc.
- Genzyme Corporation
- Asahi Kasei Corporation
- Promega Corporation
- Cytiva
- Amano Enzyme Inc.
Middle East and Africa Medical Enzyme Technology Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 176.7 Million |
| Market Size by 2028 | US$ 245.2 Million |
| Global CAGR (2021 - 2028) | 4.8% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Enzyme Type
|
| Regions and Countries Covered | Middle East and Africa
|
| Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Recent Reports
Testimonials
I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
YUKIHIKO ADACHI CEO, Deep Blue, LLC.
We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.
PIYUSH NAGPAL Sr. Vice President, High Beam Global
I requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.
Jean-Herve Jenn Chairman, Future Analytica
This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.
John Suzuki President and Chief Executive Officer, Board Director, BK TechnologiesReason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
- Merck Kgaa
- Thermo Fisher Scientific Inc.
- Novozymes
- Takeda Pharmaceutical Company Limited
- Agilent Technologies, Inc.
- Genzyme Corporation
- Asahi Kasei Corporation
- Promega Corporation
- Cytiva
- Amano Enzyme Inc.
Get Free Sample For